OraPharma Partners with Alex Rodriguez to Raise Awareness on Managing Gum Disease

OraPharma, the oral health care business of Bausch Health Companies Inc., has joined forces with World Series Champion Alex Rodriguez to initiate a nationwide awareness campaign on the prevalence and impact of gum disease.

The Cover Your Bases campaign aims to provide educational resources about the disease while encouraging patients to engage in comprehensive treatment discussions with their dentists. The campaign’s launch aligns with Oral Health Month, observed throughout June, with Alex Rodriguez serving as a patient ambassador.

New Consensus Report Confirms Link Between Gum Disease and Systemic Diseases

Widespread Impact of Gum Disease

According to the American Dental Association, gum disease affects a significant number of Americans, with an estimated 65 million individuals nationwide being affected. Specifically, nearly half of Americans aged 30 and above, along with 70% of those aged 75 and older, experience some form of gum disease.

Common symptoms of gum disease include bleeding during or after brushing and swollen or red gums. Research suggests that gum disease may also contribute to an increased risk of other chronic conditions such as diabetes and heart disease.

Alex Rodriguez shared his personal experience, saying, “Throughout my life and career, I’ve always prioritized my health, which is why I was taken aback when my dentist informed me that I had early-stage gum disease. Learning that gum disease is more prevalent among men and in Latino communities, I felt compelled to share my story. Catching it early was fortunate, and I believe if it can happen to me, it can happen to anyone.”

New research links gum disease to pancreatic cancer risk

Comprehensive Treatment Approaches for Gum Disease

While there is no cure for gum disease, it is crucial to consider comprehensive treatment plans that may involve the use of ARESTIN. ARESTIN is an antibiotic used in combination with scaling and root planing (SRP) to address adult periodontitis, commonly known as gum disease. This medication is applied directly at the site of infection, assisting in combating the bacteria responsible for gum disease. ARESTIN can be integrated into an overall health program that includes proper brushing and flossing habits, along with SRP.

It is important to note that individuals who are allergic to minocycline or tetracyclines should not use ARESTIN. If unsure, patients can consult their dentist or pharmacist for a list of these drugs. The use of tetracycline class drugs, including ARESTIN, during tooth development may result in permanent discoloration of the teeth. Therefore, it is not recommended for use in children, pregnant women, or nursing mothers. Additional Important Safety Information regarding ARESTIN can be found on the official website.

Promoting Awareness and Empowering Patients

Tom Stern, Vice President and General Manager at OraPharma, expressed enthusiasm for this groundbreaking campaign, stating, “This campaign marks a significant milestone for OraPharma. We are thrilled to have Alex onboard, not only to raise awareness about this often misunderstood and underdiagnosed disease but also to encourage patients to engage in meaningful conversations with their dentists.

“Our hope is that this campaign will shed light on gum disease and empower individuals to take control of their dental health by exploring appropriate treatment options to effectively manage this serious condition.”